Efficacy And Safety Of Terlipressin Vs Octreotide As Adjuvant Therapy In Bleeding Esophageal Varices

Trial Profile

Efficacy And Safety Of Terlipressin Vs Octreotide As Adjuvant Therapy In Bleeding Esophageal Varices

Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Sep 2007

At a glance

  • Drugs Octreotide (Primary) ; Terlipressin (Primary)
  • Indications Variceal haemorrhage
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Sep 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top